Literature DB >> 18408116

Uveitis and tumour necrosis factor blockade in ankylosing spondylitis.

L C Coates, D G McGonagle, A N Bennett, P Emery, H Marzo-Ortega.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18408116     DOI： 10.1136/ard.2007.077370

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  New onset or exacerbation of uveitis with infliximab: paradoxical effects?

Authors:  Chiharu Iwahashi; Hikari Ono; Mami Haruta; Takamasa Minami; Hisashi Mashimo; Hiroshi Shimojo; Nobuyuki Ohguro
Journal:  BMJ Open Ophthalmol       Date:  2019-07-07

2.  Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

Authors:  M Rudwaleit; E Rødevand; P Holck; J Vanhoof; M Kron; S Kary; H Kupper
Journal:  Ann Rheum Dis       Date:  2008-07-28       Impact factor: 19.103

Review 3.  A review of ocular adverse events of biological anti-TNF drugs.

Authors:  Fernanda Nicolela Susanna; Carlos Pavesio
Journal:  J Ophthalmic Inflamm Infect       Date:  2020-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.